MI insignificantly changed by hormone therapy

Merz, Noel Bairey; Adams, Stacey; Haigh, Christine; Kalvaitis, Katie
March 2008
Endocrine Today;3/10/2008, Vol. 6 Issue 4, p23
The article discusses the effect of hormone therapy to coronary heart disease in younger postmenopausal women. Researchers at the University of Pennsylvania analyzed data from a younger group, women aged 50 to 55 and compared data from unexposed and exposed women treated with estrogen and norgestrel and concluded that hormone therapy did not significantly alter myocardial infarction.


Related Articles

  • Coronary heart disease in relation to age, sex, and the menopause. Heller, R.F.; Jacobs, H.S. // British Medical Journal;2/25/1978, Vol. 1 Issue 6111, p472 

    Examines the differences between men and women in mortality from coronary heart disease (CHD) to test the consistency with this and other hypothesis. Observation suggesting the loss of a factor that had previously put men at extra risk of developing CHD at around age 50; Risk factors of male...

  • Trial results refute cardiac benefit of estrogen-progestin.  // Geriatrics;Oct98, Vol. 53 Issue 10, p15 

    Reports that according to researchers from the Heart and estrogen/progestin Replacement Study (HERS), the combination therapy of estrogen-progestin does not reduce the risk of heart attack and other coronary events in postmenopausal women who have coronary heart disease. Information on the...

  • Is hormone replacement the key to a longer life? Day, Michael // New Scientist;04/12/97, Vol. 154 Issue 2077, p12 

    Provides an update on the beneficial effects of hormone replacement therapy for women past menopause. Longer life due to reduced risk of coronary heart disease; Side effects.

  • The Heart and Estrogen/Progestin Replacement Study: What Have We Learned and What Questions Remain? Wells, G.; Herrington, D.M. // Drugs & Aging;1999, Vol. 15 Issue 6, p419 

    The Heart and Estrogen/Progestin Replacement Study (HERS) was the first randomised, double-blind, placebo-controlled study to evaluate the outcome of hormone replacement therapy (HRT) on subsequent cardiac events in postmenopausal women with established coronary heart disease (CHD). Of the 2763...

  • HRT does not prevent heart disease. Tanne, Janice Hopkins // BMJ: British Medical Journal (International Edition);8/16/2003, Vol. 327 Issue 7411, p359 

    Discusses how hormone replacement therapy (HRT) does not prevent coronary heart disease. Consideration of a medical trial that compared the combined estrogen and progestogen treatment with placebo; Risk of myocardial infarction and death in women who were given a placebo; Role of oestrogen in...

  • One conclusion may hide another.  // CMAJ: Canadian Medical Association Journal;8/20/2002, Vol. 167 Issue 4, p329 

    Editorial. Comments on the ending of a study on hormone replacement therapy (HRT) by the Women's Health Initiative (WHI). Women in the trial who experienced higher rates of stroke and breast cancer, and of coronary artery disease and pulmonary embolism; Authors in this issue who comment on the...

  • Hormone therapy decreases heart disease risk by lowering Lp(a).  // Modern Medicine;Jan97, Vol. 65 Issue 1, p15 

    Reports on a Finnish study led by Andrew G. Bostom showing the effectiveness of hormone replacement therapy (HRT) in reducing the risk of coronary disease in post-menopausal women. Reduction of blood levels of lipoprotein(a).

  • Hormone replacement therapy: a time for pause. Yusuf, Salim; Anand, Sonia // CMAJ: Canadian Medical Association Journal;8/20/2002, Vol. 167 Issue 4, p357 

    Comments on hormone-replacement therapy (HRT) for menopause, and associated health risks for women. Mention of the Women's Health Initiative (WHI), which was established to address the balance of benefit versus risks of long-term use of HRT; Suggestion that the potential reductions in coronary...

  • Postmenopausal Hormone Use and Secondary Prevention of Coronary Events in the Nurses' Health Study. Grodstein, Francine; Manon, JoAnn E.; Stampfer, Meir J. // Annals of Internal Medicine;7/3/2001, Vol. 135 Issue 1, p1 

    Discusses results of a study on the effectiveness of postmenopausal hormone use in the secondary prevention of coronary events. Patient characteristics; Decreasing recurrence of major coronary heart disease events with increasing duration of hormone use; Absence of difference between users of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics